How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

Ondřej Májek; Marek Babjuk; Monique J. Roobol; Ola Bratt; Hendrik Van Poppel; Roman Zachoval; Jiří Ferda; Marcela Koudelková; Ondřej Ngo; Jakub Gregor; Sarah Collen; Karel Hejduk; Ladislav Dušek; Vlastimil Válek

doi:10.1016/j.euros.2023.05.011

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

Ondřej Májek^*, Marek Babjuk, Monique J. Roobol, Ola Bratt, Hendrik Van Poppel, Roman Zachoval, Jiří Ferda, Marcela Koudelková, Ondřej Ngo, Jakub Gregor, Sarah Collen, Karel Hejduk, Ladislav Dušek, Vlastimil Válek

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

9 Citations (Scopus)

14 Downloads (Pure)

Abstract

An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration. Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.

Original language	English
Pages (from-to)	106-108
Number of pages	3
Journal	European Urology Open Science
Volume	53
DOIs	https://doi.org/10.1016/j.euros.2023.05.011
Publication status	Published - Jul 2023

Bibliographical note

Funding/Support and role of the sponsor: This work was supported within the framework of the European Social Fund, Operation Programme Employment (National Coordination Centre for Disease Early Detection Programmes, grant no. CZ.03.2.63/0.0/0.0/15_039/0006904). The sponsor played no role in the design and conduct of the study, interpretation of the data, and preparation of the manuscript.

Publisher Copyright: © 2023 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.euros.2023.05.011Licence: CC BY

1-s2.0-S2666168323002525-mainFinal published version, 274 KBLicence: CC BY

Cite this

Májek, O., Babjuk, M., Roobol, M. J., Bratt, O., Van Poppel, H., Zachoval, R., Ferda, J., Koudelková, M., Ngo, O., Gregor, J., Collen, S., Hejduk, K., Dušek, L., & Válek, V. (2023). How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration. European Urology Open Science, 53, 106-108. https://doi.org/10.1016/j.euros.2023.05.011

@article{bb6b121b603b4235bbf8eda9e3bcb9dd,

title = "How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration",

abstract = "An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration. Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.",

author = "Ond{\v r}ej M{\'a}jek and Marek Babjuk and Roobol, {Monique J.} and Ola Bratt and {Van Poppel}, Hendrik and Roman Zachoval and Ji{\v r}{\'i} Ferda and Marcela Koudelkov{\'a} and Ond{\v r}ej Ngo and Jakub Gregor and Sarah Collen and Karel Hejduk and Ladislav Du{\v s}ek and Vlastimil V{\'a}lek",

note = "Funding/Support and role of the sponsor: This work was supported within the framework of the European Social Fund, Operation Programme Employment (National Coordination Centre for Disease Early Detection Programmes, grant no. CZ.03.2.63/0.0/0.0/15_039/0006904). The sponsor played no role in the design and conduct of the study, interpretation of the data, and preparation of the manuscript. Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = jul,

doi = "10.1016/j.euros.2023.05.011",

language = "English",

volume = "53",

pages = "106--108",

journal = "European Urology Open Science",

issn = "2666-1691",

publisher = "Elsevier",

}

Májek, O, Babjuk, M, Roobol, MJ, Bratt, O, Van Poppel, H, Zachoval, R, Ferda, J, Koudelková, M, Ngo, O, Gregor, J, Collen, S, Hejduk, K, Dušek, L & Válek, V 2023, 'How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration', European Urology Open Science, vol. 53, pp. 106-108. https://doi.org/10.1016/j.euros.2023.05.011

TY - JOUR

T1 - How to follow the new EU Council recommendation and improve prostate cancer early detection

T2 - the Prostaforum 2022 declaration

AU - Májek, Ondřej

AU - Babjuk, Marek

AU - Roobol, Monique J.

AU - Bratt, Ola

AU - Van Poppel, Hendrik

AU - Zachoval, Roman

AU - Ferda, Jiří

AU - Koudelková, Marcela

AU - Ngo, Ondřej

AU - Gregor, Jakub

AU - Collen, Sarah

AU - Hejduk, Karel

AU - Dušek, Ladislav

AU - Válek, Vlastimil

N1 - Funding/Support and role of the sponsor: This work was supported within the framework of the European Social Fund, Operation Programme Employment (National Coordination Centre for Disease Early Detection Programmes, grant no. CZ.03.2.63/0.0/0.0/15_039/0006904). The sponsor played no role in the design and conduct of the study, interpretation of the data, and preparation of the manuscript. Publisher Copyright: © 2023 The Author(s)

PY - 2023/7

Y1 - 2023/7

N2 - An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration. Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.

AB - An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration. Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.

UR - http://www.scopus.com/inward/record.url?scp=85161548000&partnerID=8YFLogxK

U2 - 10.1016/j.euros.2023.05.011

DO - 10.1016/j.euros.2023.05.011

M3 - Comment/Letter to the editor

C2 - 37441346

AN - SCOPUS:85161548000

SN - 2666-1691

VL - 53

SP - 106

EP - 108

JO - European Urology Open Science

JF - European Urology Open Science

ER -

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this